Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Flow cytometry of platelet-leukocyte aggregates may permit monitoring of platelet function
November 18th, 2005
According to recent research published in the journal Seminars in Thrombosis and Hemostasis, flow cytometric measurement of platelet-leukocyte aggregates (PLAs) may permit monitoring of platelet function. "Increased PLA formation has been reported in acute coronary syndromes (ACS) and during cardiopulmonary bypass, and PLA formation has been acknowledged as a possible target for antiplatelet therapy in ACS and coronary interventions. It has also been suggested as a monitoring tool for risk stratification parameters," wrote U. Klinkhardt and colleagues, University of Frankfurt Hospital. Using "acontrolled study design as well as under clinical...
Source: Drug Week (2005-11-18)
|
